Results 201 to 210 of about 101,449 (340)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) study

Headache: The Journal of Head and Face Pain, Volume 65, Issue 4, Page 589-607, April 2025.
Abstract Objective To estimate rates of migraine progression and assess predictors of progression in a large, longitudinal cohort study using the traditional definition and two alternative definitions of migraine progression. Background Traditionally, migraine progression is defined as moving from episodic migraine (EM) with ≤ 14 monthly headache days (
Dawn C. Buse, E. Jolanda Muenzel, Anthony J. Zagar, Ali Sheikhi Mehrabadi, Robert E. Shapiro, Gilwan Kim, Sait Ashina, Robert A. Nicholson, Richard B. Lipton   +8 more
wiley   +1 more source

Modulation by verapamil of hormonal action on the Henle's loop of mice

, 1986
Katsuji Takeda, Shozo Torikai, Yasushi Asano, Masashi Imai   +3 more
openalex   +1 more source

The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes

Journal of Cardiovascular Electrophysiology, Volume 36, Issue 4, Page 813-823, April 2025.
ABSTRACT Background The epidemiological landscape and treatment efficacy of atrial fibrillation (AF) in the Middle East, notably in the United Arab Emirates (UAE), remain under‐explored, presenting a distinct demographic and clinical pattern compared to Western populations.
Moutaz El Kadri, Khalid AlMuti, Amrish Agrawal, Nooshin Bazargani, Mohamed Fathy Soliman Gamaleldin, Haytham Mohamed Ahmed, Omneya Hassanain, Natasha Khalife, Ghazi Radaideh, Mohamed Magdy, Wael A. Almahmeed   +10 more
wiley   +1 more source

Targeting Txnip-mediated metabolic reprogramming has therapeutic potential for osteoarthritis. [PDF]

Cell Death Discov
Cao X, Yang X, Zhang P, Xu J, Zhao J, Yang E.   +5 more
europepmc   +1 more source

DIFFERENTIAL EFFECTS OF THE CALCIUM ANTAGONIST, VERAPAMIL, ON LUMEN SIZES OF TERMINAL ARTERIOLES AND MUSCULAR VENULES IN THE RAT MESENTERIC, PIAL AND SKELETAL MUSCLE MICROVASCULATURES [PDF]

, 1980
Burton M. Altura, Bella T. Altura, Asefa Gebrewold   +2 more
openalex   +1 more source

OS‐01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12‐Week Clinical Trial

Journal of Cosmetic Dermatology, Volume 24, Issue 4, April 2025.
ABSTRACT Objective As the body's largest organ, the skin plays a crucial role in defending against external stressors. Skin characteristics change with age, decreasing skin barrier integrity and compromising skin and body health. This study aimed to investigate the potential of a topical formulation containing OS‐01 (a.k.a.
Alessandra Zonari, Lear E. Brace, Luiza Brunelli Buhrer, Nathaniel H. O. Harder, Claire Harker, Adam B. Aronson, Caitlyn N. Tse, Carolina R. Oliveira, Mariana Boroni, Juliana L. Carvalho   +9 more
wiley   +1 more source

Effects of Ro 40-5967, a Novel Calcium Antagonist, on Myocardial Function During Ischemia Induced by Lowering Coronary Perfusion Pressure in Dogs: Comparison with Verapamil

, 1989
Jean‐Paul Clozel, Ludger Banken, Wolfgang Osterrieder   +2 more
openalex   +1 more source

Modelling Hollow Microneedle-Mediated Drug Delivery in Skin Considering Drug Binding. [PDF]

Pharmaceutics
Bhuimali T, Sarifuddin, Das DB, Mandal PK.   +3 more
europepmc   +1 more source

EFFECT OF VERAPAMIL ON POSTTRANSPLANT ACUTE RENAL FAILURE IN THE CANINE KIDNEY

, 1988
PETER J. GOLUEKE, Kim U. Kahng, George S. Lipkowitz, P A O'Neill, Richard B. Wait   +4 more
openalex   +1 more source

Effect of salmon calcitonin combined with calcium antagonist on blood calcium and phosphorus ion concentration in osteoporosis rats. [PDF]

Eur J Med Res
Chen J, Wang J, Jia W, Zhang Y, Li H, Liu S, Sun H.   +6 more
europepmc   +1 more source